Portola Pharmaceuticals, Inc. Research and Development Expense
Portola Pharmaceuticals, Inc. reported Research and Development Expense of $26.09 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2020-05-11
- Portola Pharmaceuticals, Inc. research and development expense for the quarter ending 2020-03-31 was $26.09M, a 26.68% decline year-over-year.
- Portola Pharmaceuticals, Inc. research and development expense for the quarter ending 2019-12-31 was $29.86M, a 39.63% decline year-over-year.
- Portola Pharmaceuticals, Inc. research and development expense for the quarter ending 2019-09-30 was $25.65M, a 36.26% decline year-over-year.
- Portola Pharmaceuticals, Inc. research and development expense for the quarter ending 2019-06-30 was $33.54M, a 49.52% decline year-over-year.
- Portola Pharmaceuticals, Inc. research and development expense for fiscal 2019 was $124.63M, a 42.36% decline from fiscal 2018.
- Portola Pharmaceuticals, Inc. research and development expense for fiscal 2018 was $216.21M, a 6.14% increase from fiscal 2017.
- Portola Pharmaceuticals, Inc. research and development expense for fiscal 2017 was $203.70M, a 17.48% decline from fiscal 2016.
- Portola Pharmaceuticals, Inc. research and development expense for fiscal 2016 was $246.85M, a 23.20% increase from fiscal 2015.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2020-03-31 | $26.09M 10-Q · filed 2020-05-11 | $55.95M derived: sum of 2 quarters · filed 2020-05-11 | $81.59M derived: sum of 3 quarters · filed 2020-05-11 | $115.13M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | $29.86M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $55.51M derived: sum of 2 quarters · filed 2020-02-28 | $89.04M derived: sum of 3 quarters · filed 2020-02-28 | $124.63M 10-K · filed 2020-02-28 |
| 2019-09-30 | $25.65M 10-Q · filed 2019-11-05 | $59.19M derived: sum of 2 quarters · filed 2019-11-05 | $94.77M 10-Q · filed 2019-11-05 | $144.23M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | $33.54M 10-Q · filed 2019-08-07 | $69.12M 10-Q · filed 2019-08-07 | $118.58M derived: sum of 3 quarters · filed 2020-05-11 | $158.82M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-03-31 | $35.58M 10-Q · filed 2020-05-11 | $85.05M derived: sum of 2 quarters · filed 2020-05-11 | $125.28M derived: sum of 3 quarters · filed 2020-05-11 | $191.72M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $49.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $89.70M derived: sum of 2 quarters · filed 2020-02-28 | $156.14M derived: sum of 3 quarters · filed 2020-02-28 | $216.21M 10-K · filed 2020-02-28 |
| 2018-09-30 | $40.24M 10-Q · filed 2019-11-05 | $106.68M derived: sum of 2 quarters · filed 2019-11-05 | $166.74M 10-Q · filed 2019-11-05 | $235.24M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $66.44M 10-Q · filed 2019-08-07 | $126.51M 10-Q · filed 2019-08-07 | $195.00M derived: sum of 3 quarters · filed 2020-02-28 | $250.27M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $60.07M 10-Q · filed 2019-05-08 | $128.56M derived: sum of 2 quarters · filed 2020-02-28 | $183.83M derived: sum of 3 quarters · filed 2020-02-28 | $233.12M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $68.49M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $123.76M derived: sum of 2 quarters · filed 2020-02-28 | $173.06M derived: sum of 3 quarters · filed 2020-02-28 | $203.70M 10-K · filed 2020-02-28 |
| 2017-09-30 | $55.27M 10-Q · filed 2018-11-07 | $104.56M derived: sum of 2 quarters · filed 2018-11-07 | $135.21M 10-Q · filed 2018-11-07 | $191.24M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $49.29M 10-Q · filed 2018-08-09 | $79.94M 10-Q · filed 2018-08-09 | $135.97M derived: sum of 3 quarters · filed 2019-03-01 | $223.18M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $30.64M 10-Q · filed 2018-05-10 | $86.68M derived: sum of 2 quarters · filed 2019-03-01 | $173.89M derived: sum of 3 quarters · filed 2019-03-01 | $218.71M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $56.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $143.24M derived: sum of 2 quarters · filed 2019-03-01 | $188.06M derived: sum of 3 quarters · filed 2019-03-01 | $246.85M 10-K · filed 2019-03-01 |
| 2016-09-30 | $87.21M 10-Q · filed 2017-11-09 | $132.03M derived: sum of 2 quarters · filed 2017-11-09 | $190.82M 10-Q · filed 2017-11-09 | $250.66M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $44.82M 10-Q · filed 2017-08-09 | $103.64M 10-Q · filed 2017-08-09 | $163.45M derived: sum of 3 quarters · filed 2018-03-01 | $211.85M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $58.81M 10-Q · filed 2017-05-09 | $118.63M derived: sum of 2 quarters · filed 2018-03-01 | $167.03M derived: sum of 3 quarters · filed 2018-03-01 | $219.33M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $59.81M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $108.22M derived: sum of 2 quarters · filed 2018-03-01 | $160.52M derived: sum of 3 quarters · filed 2018-03-01 | $200.38M 10-K · filed 2018-03-01 |
| 2015-09-30 | $48.41M 10-Q · filed 2016-11-07 | $100.70M derived: sum of 2 quarters · filed 2016-11-07 | $140.56M 10-Q · filed 2016-11-07 | $175.28M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $52.30M 10-Q · filed 2016-08-09 | $92.16M 10-Q · filed 2016-08-09 | $126.88M derived: sum of 3 quarters · filed 2017-03-01 | $158.66M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $39.86M 10-Q · filed 2016-05-06 | $74.58M derived: sum of 2 quarters · filed 2017-03-01 | $106.36M derived: sum of 3 quarters · filed 2017-03-01 | $135.34M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $34.72M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $66.50M derived: sum of 2 quarters · filed 2017-03-01 | $95.48M derived: sum of 3 quarters · filed 2017-03-01 | $123.64M 10-K · filed 2017-03-01 |
| 2014-09-30 | $31.78M 10-Q · filed 2015-11-09 | $60.76M derived: sum of 2 quarters · filed 2015-11-09 | $88.92M 10-Q · filed 2015-11-09 | $111.56M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $28.98M 10-Q · filed 2015-08-05 | $57.14M 10-Q · filed 2015-08-05 | $79.78M derived: sum of 3 quarters · filed 2016-02-29 | $97.87M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $28.16M 10-Q · filed 2015-05-07 | $50.80M derived: sum of 2 quarters · filed 2016-02-29 | $68.89M derived: sum of 3 quarters · filed 2016-02-29 | $89.72M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $22.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $40.73M derived: sum of 2 quarters · filed 2016-02-29 | $61.56M derived: sum of 3 quarters · filed 2016-02-29 | $79.29M 10-K · filed 2016-02-29 |
| 2013-09-30 | $18.09M 10-Q · filed 2014-11-10 | $38.92M derived: sum of 2 quarters · filed 2014-11-10 | $56.64M 10-Q · filed 2014-11-10 | $70.36M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $20.83M 10-Q · filed 2014-08-06 | $38.56M 10-Q · filed 2014-08-06 | $52.27M derived: sum of 3 quarters · filed 2015-03-02 | $62.22M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $17.72M 10-Q · filed 2014-05-13 | $31.43M derived: sum of 2 quarters · filed 2015-03-02 | $41.39M derived: sum of 3 quarters · filed 2015-03-02 | $54.48M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $13.71M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $23.67M derived: sum of 2 quarters · filed 2015-03-02 | $36.76M derived: sum of 3 quarters · filed 2015-03-02 | $49.72M 10-K · filed 2015-03-02 |
| 2012-09-30 | $9.95M 10-Q · filed 2013-11-06 | $23.04M derived: sum of 2 quarters · filed 2013-11-06 | $36.00M 10-Q · filed 2013-11-06 | |
| 2012-06-30 | $13.09M 10-Q · filed 2013-08-14 | $26.05M 10-Q · filed 2013-08-14 | ||
| 2011-12-31 | $46.09M 10-K · filed 2014-03-03 |